Welcure Drugs & Pharmaceuticals Ltd. BSE: 524661

Mid-range Performer

Download real time

8.39 -0.44 (-4.98%)

47.20% Fall from 52W High

3.0M

BSE Volume

BSE 15 Sep, 2025 3:31 PM (IST)

Board Meeting

The next board meeting for Welcure Drugs & Pharmaceuticals Ltd. is on 25 Sep 2025 for the purpose of Others See details

Welcure Drugs & Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Welcure Drugs & Pharmaceuticals Ltd. on BSE

Load latest

Welcure Drugs & Pharmaceuticals Ltd.

06 May 2025

8.39

-4.98%

Board Meeting

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting …

BSE India

Outcome of the Meeting of Board of Directors of Welcure Drugs & Pharmaceuticals Ltd.held on today i.e Tuesday 06th May 2025

Welcure Drugs & Pharmaceuticals Ltd.

06 May 2025

8.39

-4.98%

Company Update

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial …

BSE India

Intimation of Resignation of Chief Financial officer under regulation 30 of SEBI(LODR) Regulation 2015

Welcure Drugs & Pharmaceuticals Ltd.

06 May 2025

8.39

-4.98%

Company Update

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director

BSE India

Intimation of Resignation of Managing Director under regulation 30 of SEBI(LODR) Regulation 2015

Welcure Drugs & Pharmaceuticals Ltd.

30 Apr 2025

8.39

-4.98%

Corp. Note

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Format of the Initial Disclosure to be made …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyWelcure Drugs & Pharmaceuticals Ltd 2CIN NO.L24232DL1996PLC227773 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Altaf Hussain Shah Designation: Managing Director EmailId: welcuredrugs227@gmail.com Name of the Chief Financial Officer: Altaf Hussani Shah Designation: CFO EmailId: welcuredrugs227@gmail.com Date: 30/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Welcure Drugs & Pharmaceuticals Ltd.

10 Apr 2025

8.39

-4.98%

Company Update

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Certificate under Regulation 74(5) of SEBI(Depository and participants)Regulations,2018 for the Quarter and year ended 31st March 2025.

Welcure Drugs & Pharmaceuticals Ltd.

27 Mar 2025

8.39

-4.98%

SAST

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Closure of Trading Window

BSE India

Closure of Trading Window

Welcure Drugs & Pharmaceuticals Ltd.

25 Feb 2025

8.39

-4.98%

AGM

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Result of Postal Ballot and Disclosure under Regulation 30, Schedule III, Part A(13)of SEBI (LODR)Regulation 2015.

Welcure Drugs & Pharmaceuticals Ltd.

21 Feb 2025

8.39

-4.98%

Company Update

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary …

BSE India

Intimation of Resignation of Company Secretary and compliance officer under regulation 30 of the SEBI(LODR)Regulation 2015.

Welcure Drugs & Pharmaceuticals Ltd.

17 Feb 2025

8.39

-4.98%

Company Update

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Clipping of Unaudited Financial Results of Quarter ended December, 2024

Welcure Drugs & Pharmaceuticals Ltd.

14 Feb 2025, 06:12PM

8.39

-4.98%

Corp. Note

WELCURE DRUGS & PHARMACEUTICALS LTD. - 524661 - Integrated Filing (Financial)

BSE India

INTEGRATED FILING FOR THE QUARTER AND NINE MONTH ENDED DECEMBER 31 2024.

Is Welcure Drugs & Pharmaceuticals Ltd. worth buying?

51 Votes:

Buy 74.51%

Sell 9.8%

Hold 15.69%